Full Press Release Details
CRISPR Therapeutics to Participate in Citi's 18th Annual Biopharma Conference.
CRSP
CRISPR Therapeutics to Participate in Citi's 18th Annual Biopharma Conference
Key Takeaway: CRISPR Therapeutics to Participate in Citi's 18th Annual Biopharma Conference
Price reaction · baseline $50.57 (2023-08-29 close) · hit after-hours · clean, no other CRSP news in the window
day 0 close · peak
-0.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.4%
average across 2 past catalysts
Cash runway
~84 mo
Minimal dilution risk
Lead asset
CTX340
Phase 1 · Hypertension